Your browser doesn't support javascript.
loading
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Su, Christopher T; Nizialek, Emily; Berchuck, Jacob E; Vlachostergios, Panagiotis J; Ashkar, Ryan; Sokolova, Alexandra; Barata, Pedro C; Aggarwal, Rahul R; McKay, Rana R; Agarwal, Neeraj; McClure, Heather M; Nafissi, Nellie; Bryce, Alan H; Sartor, Oliver; Sayegh, Nicolas; Cheng, Heather H; Adra, Nabil; Sternberg, Cora N; Taplin, Mary-Ellen; Cieslik, Marcin; Alva, Ajjai S; Antonarakis, Emmanuel S.
Affiliation
  • Su CT; Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Nizialek E; Rogel Cancer Center, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Berchuck JE; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Vlachostergios PJ; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Ashkar R; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Sokolova A; Department of Medicine, Indiana University, Indianapolis, Indiana, USA.
  • Barata PC; Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Aggarwal RR; Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
  • McKay RR; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Agarwal N; Department of Medicine, University of California San Diego, San Diego, California, USA.
  • McClure HM; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Nafissi N; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Bryce AH; Department of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Sartor O; Department of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Sayegh N; Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
  • Cheng HH; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Adra N; Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Sternberg CN; Department of Medicine, Indiana University, Indianapolis, Indiana, USA.
  • Taplin ME; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Cieslik M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Alva AS; Rogel Cancer Center, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Antonarakis ES; Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Prostate ; 83(3): 227-236, 2023 02.
Article in En | MEDLINE | ID: mdl-36382533
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Poly(ADP-ribose) Polymerase Inhibitors Limits: Humans / Male Language: En Journal: Prostate Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Poly(ADP-ribose) Polymerase Inhibitors Limits: Humans / Male Language: En Journal: Prostate Year: 2023 Type: Article Affiliation country: United States